| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f57a53515b98afbb284cb39a2f17f7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
| filingDate |
2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_634f8d1e50258d2adef7e666d755b4f6 |
| publicationDate |
2016-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016179207-A1 |
| titleOfInvention |
Deuterated filgotinib |
| abstract |
This invention relates to deuterated forms of filgotinib, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a JAK inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021023207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112851682-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017133423-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017106564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020201975-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113677676-A |
| priorityDate |
2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |